Venous thromboembolism treatment outcomes in cancer patients and effect of third-party payers on anticoagulant choice

Gary W. Jean,Katherine Kelly,Jennie Mathew,Eneko Larumbe,Randall S. Hughes

Venous thromboembolism treatment outcomes in cancer patients and effect of third-party payers on anticoagulant choice

2017

Gary W. Jean
Katherine Kelly
Jennie Mathew
Eneko Larumbe
Randall S. Hughes

Purpose The purpose of this study is to compare the rates of recurrent VTE among cancer patients treated with parenteral agents to the oral anticoagulants.

Keywords:

Intensive care medicine
Third-Party Payers
Anticoagulant
Low molecular weight heparin
Cancer
Medicine
Warfarin
treatment outcome
venous thromboembolism
anticoagulation management

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations